Dupilumab, a simple pre-filled pen that people inject themselves with every two weeks, is the first biologic that targets both the symptoms of COPD and an underlying cause of the disease. It brings ...

NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...

The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...

A major trial finds the beta blocker bisoprolol neither improves nor worsens outcomes in people with COPD, despite the cardiovascular risk.

An AI-powered model that analyzes electrocardiograms was able to accurately detect COPD early in internal testing and ...

NICE has estimated that around 40% of people with COPD have elevated blood levels of eosinophils and, if half the eligible ...

LEWISBURG, WV (WVNS) — Springtime is considered by many to be the roughest season for those with chronic lung conditions like ...

NICE has approved the first targeted treatment for chronic obstructive pulmonary disease (COPD), offering a new option to up ...

Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...

A biologic injection that reduces chronic obstructive pulmonary disease (COPD) flare-ups by around a third has been approved for use on the NHS in England and Wales. The National Institute for Health ...

Electronic cigarettes—or vapes—can release puffs of vapor in aromatic clouds. The health risks of breathing in this ...